Evidence map›Paper›PMID 36444570›Full record

SynthesisAsian Pacific journal of cancer prevention : APJCP2022

Prevalence and Epidemiological Profile of Ameloblastoma in India: A Systematic Review and Meta-Analyses.

Yoithapprabhunath Thuckanaickenpalayam Ragunathan, Srichinthu Keniyan Kumar, Dineshshankar Janardhanam, Aravindhan Ravi, Vidyalakshmi Santhanam, Madhavan Nirmal Ramdas

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Asian Pacific journal of cancer prevention : APJCP, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yoithapprabhunath Thuckanaickenpalayam RagunathanDepartment of Oral and Maxillofacial Pathology, Vivekanandha Dental College for Women, Tamilnadu, India.ORCID 0000-0001-6084-369X
Srichinthu Keniyan KumarDepartment of Oral & Maxillofacial Pathology, KSR Institute of Dental Science and Research, Tamilnadu-637215, India.
Dineshshankar JanardhanamDepartment of Oral and Maxillofacial Pathology, Vivekanandha Dental College for Women, Tamilnadu, India.
Aravindhan RaviDepartment of Oral & Maxillofacial Pathology, SRM Kattankulathur Dental College and Hospital, Chennai, India.
Vidyalakshmi SanthanamDepartment of Oral & Maxillofacial Pathology, Indira Gandhi Institute of Dental Sciences, Sri Balaji Vidyapeeth University, Pondicherry, India.ORCID 0000-0001-6556-4518
Madhavan Nirmal RamdasDepartment of Oral & Maxillofacial Pathology, Rajah Muthiah Dental College & Hospital, Annamalai University, Tamil Nadu, India.
Vokkaligara Sangha Dental College & Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAmeloblastoma is regarded as the second most prevalent odontogenic tumor in the light of its prevalence, clinical characteristics, greater incidence of tumor recurrence, and therapeutic challenges. The aim of this systematic review was to establish the prevalence of ameloblastoma in the Indian subcontinent and to establish a national epidemiologic profile for these lesions. MATERIAL AND

methodsA systematic review was undertaken based on the PRISMA guidelines in search of epidemiologic studies concerning odontogenic tumors and ameloblastoma that are listed by PubMed, EBSCO, and Google Scholar embracing the period from January 2010 to December 2021, to evaluate the prevalence rate in India. A total of 277 publications were retrieved, of which 27 articles were selected, based on the World Health Organization classification of odontogenic tumors.

resultsThe affected individuals were on average in the third decade of life, with a higher male predominance. The majority of the tumors were multilocular radiolucencies in the posterior mandible, with follicular and plexiform histopathological features. The most common type of malignant lesion is ameloblastic carcinoma. Over 60% of follicular ameloblastoma recurred more frequently than the other types of ameloblastoma.The random effect model shows overall point estimate of 4.83 with 95% confidence interval (4.44 -5.26).

conclusionThe systematic study indicates a slight male predisposition to ameloblastoma, with a peak incidence in the third decade of life and the mandible as the preferred anatomical site. The solid/multicystic ameloblastoma is the most prevalent histopathologic pattern. More epidemiological research on the prevalence rate of ameloblastoma is required, particularly in India, in an effort to accurately determine the national epidemiological profile of ameloblastoma.

Indexed as

AmeloblastomaOdontogenic TumorsFemaleGenotypeHumansIndiaMalePrevalenceAmeloblastomaOdontogenic tumorPrevalenceRecurrence

Identifiers

PMID36444570
PMCPMC9930951
OpenAlexW4310209551

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.